Martin William Dewhurst - 07 Jan 2026 Form 3 Insider Report for Turn Therapeutics Inc. (TTRX)

Role
Director
Signature
/s/ Zuraiz Chaudhary, attorney-in-fact for Martin William Dewhurst
Issuer symbol
TTRX
Transactions as of
07 Jan 2026
Net transactions value
$0
Form type
3
Filing time
04 Feb 2026, 07:30:21 UTC
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Dewhurst Martin William Director C/O TURN THERAPEUTICS INC., 250 N. WESTLAKE BLVD., WESTLAKE VILLAGE /s/ Zuraiz Chaudhary, attorney-in-fact for Martin William Dewhurst 04 Feb 2026 0002108597

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding TTRX Stock Option (right to buy) 07 Jan 2026 Common Stock 40,030 $4.59 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock option became exercisable as to 10,000 of the shares of common stock on July 26, 2024, and 858 shares on the last day of each month thereafter, in each case, after giving effect to the stock split as described below.
F2 The number of shares of common stock underlying the stock option and the applicable exercise price give effect to the 2-for-1 forward stock split, that took effect on September 30, 2025.

Remarks:

Exhibit 24 - Power of Attorney.